logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Procter & Gamble Health Share Price

PGHL

₹5,130

-102.50(-1.96%)
15th Oct 2026 | 3:28 PM
NSE : PGHL

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Procter & Gamble Health Share Price Today

As of 15-10-2026 18:48, Procter & Gamble Health Ltd. share price today is ₹0, with a change of ₹-5232.50 (-100.00%) from the previous close of ₹5232.5. The stock opened at ₹5258.5 and traded between ₹5122.5 and ₹5259, with a total traded volume of 8366 shares. The company has a market capitalization of ₹8685.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹6975 and ₹4707, respectively.

Procter & Gamble Health Ltd. valuation metrics include a P/E ratio of 24.3, and book value of ₹14.00. Profitability indicators show ROE of 62.32% along with a dividend yield of 3.9%. Procter & Gamble Health Ltd. has reported revenue of ₹1432.94 Cr and net profit of ₹356.88 Cr.

Procter & Gamble Health Ltd. technical indicators include Day RSI at 38.05, Day MFI at 60.83, Day ADX at 26.09. Additional indicators include Commodity Channel Index (CCI) at -69.1 and Williams %R at -84.6. Momentum indicators show Day MACD at -125.15, Day MACD Signal Line at -127.07, DayATR at 151.66. Rate of Change indicators for Procter & Gamble Health Ltd. include ROC125 at 5.94 and ROC21 at -3.31.

Exponential moving averages include EMA5 at ₹5247.1, EMA10 at ₹5286.6, EMA12 at ₹5303.9, EMA20 at ₹5374.2, EMA26 at ₹5429, EMA50 at ₹5610, EMA100 at ₹5728.6, EMA200 at ₹5723. Simple moving averages include SMA5 at ₹5218.2, SMA10 at ₹5285.4, SMA20 at ₹5379.2, SMA30 at ₹5447.9, SMA50 at ₹5643, SMA100 at ₹6011.7, SMA150 at ₹5686.9, SMA200 at ₹5602.7.

Support levels for Procter & Gamble Health are placed at First Support ₹5164.00, Second Support ₹5095.50, Third Support ₹4985.50. Resistance levels are seen at First Resistance ₹5342.50, Second Resistance ₹5452.50, Third Resistance ₹5521.00. Procter & Gamble Health Ltd. shareholding pattern shows promoter holding at 51.82%, FII holding at 6.33%, DII holding at 0%, public holding at 29.41%.

Procter & Gamble Health Performance

Price Movement

₹5130.00

₹5122.50

₹5259.00

↘ Today's Low↗ Today's High

1 Year Performance

₹5130.00

₹4707.00

₹6975.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹5,259.00
Low₹5,122.50
Open at₹5,258.50
Prev Close₹5,232.50
Volumes8.37 K
Avg Price₹5,168.95
Lower Circuit₹4,186.00
Upper Circuit₹6,279.00

Historical Performance

3M High₹6,975.00
3M Low₹5,115.00
1 Yr High₹6,975.00
1 Yr Low₹4,707.00
3 Yr High₹6,975.00
3 Yr Low₹4,636.55
5 Yr High₹6,975.00
5 Yr Low₹3,870.10

Procter & Gamble Health Fundamentals

Market Cap
Above industry Median
8,685.60 Cr.
PE Ratio (TTM)
Below industry Median
24.30
Dividend Yield
High in industry
3.90
Net Profit TTM
18.7% incr over last year
356.88
Net Profit Growth
18.7% incr over last year
356.88
PEG Ratio
Above industry Median
1.30
ROE
42.8% incr over last year
62.32
Operating Revenue TTM
1,432.94
Operating Revenue Growth
12.6% incr over last year
Book Value
High in industry
14
MFI
MFI is mid-range
60.83
RSI
RSI is mid-range
38.05
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
14

Procter & Gamble Health Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Total Revenue363.71370.45373.86324.92338.74
Operating Expense264.11234.86263.40204.65248.40
Operating Profit99.60135.59110.46120.2790.34
Depreciation0.146.175.906.085.44
Interest6.020.210.100.120.12
Tax32.9738.6131.2330.4822.63
Net Profit96.1594.6077.5988.5466.18

Procter & Gamble Health Technicals

Procter & Gamble Health Ltd. EMA & SMA

₹5130.00

-165.50 (-3.13%)

↗ Bullish Moving Average

1

↘ Bearish Moving Average

15

Day EMA5 ₹5247.1
Day EMA10 ₹5286.6
Day EMA12 ₹5303.9
Day EMA20 ₹5374.2
Day EMA26 ₹5429
Day EMA50 ₹5610
Day EMA100 ₹5728.6
Day EMA200 ₹5723

Procter & Gamble Health Support and Resistance

Resistance

First Resistance₹5342.50
Second Resistance₹5452.50
Third Resistance₹5521.00

Support

First Support₹5164.00
Second Support₹5095.50
Third Support₹4985.50

Technical Indicators

Day RSI38.05
Day MFI60.83
Day ADX26.09
Day Commodity Channel Index-69.10
William-84.60
Day MACD-125.15
Day MACD Signal Line-127.07
Day ATR151.66
Day ROC1255.94
Day ROC21-3.31

Procter & Gamble Health Shareholding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter51.851.851.851.851.851.8
FII6.977.276.26.3
DII14.214.113.913.813.712.5
Public27.1272727.428.329.4

Procter & Gamble Health Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day9.34 K14.35 K65.08%
Week4.91 K8.44 K58.16%
1 Month6.53 K13.48 K48.45%
6 Month11.78 K22.42 K52.56%

Procter & Gamble Health SWOT Analysis

Strengths24
Weakness7
Opportunity5
Threats1

MACD Crossover Above Signal Line

Companies with no Debt

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Newly Affordable Stocks with Good Financials and Durability (subscription)

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above signal line previous end of day

Volume Shockers

Procter & Gamble Health Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
27 Aug, 202645FINAL27 Aug, 2026Equity Share
12 Feb, 202650SPECIAL12 Feb, 2026Equity Share
12 Feb, 2026110INTERIM12 Feb, 2026Equity Share
22 Aug, 202545FINAL22 Aug, 2025Equity Share
21 Feb, 202580INTERIM21 Feb, 2025Equity Share
28 Nov, 202460FINALEquity Share
14 Feb, 202450INTERIM14 Feb, 2024Equity Share
14 Feb, 2024150SPECIAL14 Feb, 2024Equity Share
23 Nov, 202350FINALEquity Share
13 Feb, 202345INTERIM13 Feb, 2023Equity Share

Procter & Gamble Health Stock Comparison

Financials
Price (₹)₹1,245₹2,042₹1,012₹1,257.10₹1,433₹3,562
% Change-0.65%-0.85%-4.09%-1.90%-0.65%-1.44%
Revenue TTM (₹ Cr)-₹1,479.07₹675.61₹691.72₹1,543.34₹949.80
Net Profit TTM (₹ Cr)-₹199.03₹182.64₹126.37₹-48.62₹266
PE TTM-63.3065.3046.70-340.2031.30
1 Year Return26.8493.9477.9479.32-21.57-23.07
ROCE14.9731.5424.2215.600.59-
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on PGHL

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy